Spok Holdings Inc(SPOK) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 18.34 | EPS (ttm) | 0.58 | Insider Own | 2.2% | Shs Outstand | 20.9M | Perf Week | -0.28% |
| Market Cap | 0.22B | Forward P/E | - | EPS next Y | - | Insider Trans | 1.52% | Shs Float | 20.5M | Perf Month | -3.01% |
| Enterprise Value | 0.21B | PEG | - | EPS next Q | - | Inst Own | 57.61% | Short Float | 2.9% | Perf Quarter | -1.3% |
| Income | 0.01B | P/S | 1.64 | EPS this Y | - | Inst Trans | 2.37% | Short Ratio | 3.57 | Perf Half Y | -11.1% |
| Sales | 0.14B | P/B | 1.59 | EPS next 5Y | - | ROA | 6.06% | Short Interest | 0.59M | Perf YTD | -19.26% |
| Book/sh | 6.69 | P/C | 13.43 | EPS past 3/5Y | -11.64% - | ROE | 8.42% | 52W High | -39.83% ($17.70) | Perf Year | -39.66% |
| Cash/sh | 0.79 | P/FCF | 8.77 | Sales past 3/5Y | 1.27% -1.17% | ROIC | 8.54% | 52W Low | 7.04% ($9.95) | Perf 3Y | -28.09% |
| Dividend Est. | $1.25 (11.72%) | EV/EBITDA | 9.61 | EPS Y/Y TTM | -29.34% | Gross Margin | 62.53% | Volatility(W/M) | 1.47% 1.97% | Perf 5Y | 6.5% |
| Dividend TTM | 1.25 | EV/Sales | 1.56 | Sales Y/Y TTM | -3.39% | Oper. Margin | 13.55% | ATR (14) | 0.21 | Perf 10Y | -34.84% |
| Dividend Ex-Date | 2026/8/19 | Quick Ratio | 1.09 | EPS Q/Q | -10.94% | Profit Margin | 9% | RSI (14) | 48.85 | Recom | 3 |
| Dividend Gr. 3/5Y | - 20.11% | Current Ratio | 1.09 | Sales Q/Q | -1.89% | SMA20 | 0.34% ($10.61) | Beta | 0.44 | Target Price | $14 |
| Payout | 165.72% | Debt/Eq | 0.04 | Earnings | 2026/7/29 | SMA50 | -0.72% ($10.73) | Rel Volume | 0.52 | Prev Close | $10.63 |
| Employees | 421 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | - | SMA200 | -8.94% ($11.7) | Avg Volume(3M) | 0.17M | Price | $10.65 |
| IPO | 2002/5/30 | Option/Short | Yes/Yes | Trades | 1756 | Volume | 86,165 | Change | 0.19% |
Company
SPOK is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 A US healthcare information services company that provides clinical communication, secure messaging, and wireless paging (paging) services to hospitals, government agencies, and large corporations. Building on the reliability of paging—which works even in environments where cellular signals cannot reach inside buildings—the company has expanded its business into secure text messaging and clinical alert software for medical institutions.
Over the past 1 year, on the lower side
40% below its 1-year high.
SPOK makes money exceptionally well
13.55% of revenue is kept as operating profit.
Tap to view numbers
The stock looks undervalued
Trading at 18.3 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -28.1% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 11.72% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 57.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $223M.
FAQ
What kind of company is SPOK?
SPOK belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of SPOK?
The market cap of SPOK is approximately $223M, ranking 4,035 within its sector.
Does SPOK pay dividends?
SPOK has a dividend yield of approximately 11.72%, with an annual dividend of $1.25.
What is the P/E ratio of SPOK?
SPOK has a P/E ratio of approximately 18.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SPOK?
SPOK has recorded a 52-week high of $17.70 and a low of $9.95.